Healthcare ❯ Pharmaceuticals

Drug Regulation

FDA Quality Control Product Recalls ANMAT Prescription Practices Prescription Medications FDA Actions Public Health Codeine-based Medications FDA Policies

Securities Suit Alleges Unicycive Hid Manufacturing Oversight That Could Delay OLC Approval

Plaintiff firms are soliciting investors to join the case or seek lead‑plaintiff status before the November 2, 2026 deadline.

FDA Approves Teva’s Once-Monthly Olanzapine Injection, WELTRUZA

Multiple Law Firms Press Securities Suits Against Anavex Over Blarcamesine Setback and CEO Firing

Ahmedabad Police Arrest Three in Interstate Fake Blood-Pressure Pill Racket

Two Arrested in Latur for Selling Prescription-Only Mephentermine Injections

Bombay High Court Orders Maharashtra FDA To Revoke Cadila Stop‑Sale Orders

Former ANMAT Leaders Freed After Paying Large Property Bonds as Fentanyl Inquiry Deepens

Anvisa Allows Pharmacies to Sell Medicines Through Shopee

Supreme Court Rejects Drugmakers’ Appeals Over Medicare Price Talks

HHS Denies SSRI Ban Talks as Kennedy Unveils Push to Curb Prescribing

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Delhi Seizes 2,104 Insulin Units Over Storage, Label Violations

FDA Warns 30 Telehealth Firms Over Misleading Ads for Compounded GLP-1 Drugs

GLP‑1 Use Under Scrutiny After Study on Tolerability and Delhi OTC Sales

DOJ Seeks Pause of Louisiana Abortion-Pill Lawsuit as FDA Reopens Mifepristone Review

Telangana Orders Stop-Use of Almont-Kid Syrup After Ethylene Glycol Found

Federal Police Allege Illegal Tirzepatide Imports by Unikka in 'Operation Slim' Targeting Influencer Doctor

Mexico’s FGR Links Lawyer to Bribery Case Over Alleged Offer to Cofepris Inspectors

MHRA Pulls Kids’ Magnesium Gummies Over Undeclared Melatonin

Fourth Circuit Affirms West Virginia’s Restriction on Abortion Pill Mifepristone